STEPHEN PAPPAS

Concepts (66)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatorenal Syndrome
12
2025
29
2.750
Why?
Vasoconstrictor Agents
11
2025
132
1.210
Why?
Lypressin
9
2025
17
0.960
Why?
Hepatitis B
1
2021
166
0.640
Why?
Duty to Warn
1
2019
2
0.610
Why?
Professional Impairment
1
2019
3
0.600
Why?
Alcoholic Intoxication
1
2019
12
0.600
Why?
Confidentiality
1
2019
103
0.560
Why?
Hepatitis C Antibodies
1
2017
24
0.550
Why?
Kidney Function Tests
2
2017
121
0.540
Why?
Alcoholism
1
2019
240
0.500
Why?
Diagnostic Tests, Routine
1
2017
128
0.500
Why?
Hepacivirus
1
2017
262
0.480
Why?
Albumins
6
2023
88
0.440
Why?
Acute Kidney Injury
2
2025
601
0.250
Why?
Liver Cirrhosis
5
2023
871
0.240
Why?
Bradycardia
1
2025
56
0.230
Why?
Liver Transplantation
3
2023
1096
0.210
Why?
Respiratory Insufficiency
2
2022
238
0.200
Why?
Hepatitis, Alcoholic
1
2023
25
0.200
Why?
Hepatitis B Antibodies
1
2021
24
0.180
Why?
Hepatitis B Vaccines
1
2021
44
0.180
Why?
Arrhythmias, Cardiac
1
2025
474
0.180
Why?
Acute-On-Chronic Liver Failure
1
2022
71
0.170
Why?
Hepatitis B virus
1
2021
137
0.170
Why?
Liver Cirrhosis, Alcoholic
1
2019
39
0.150
Why?
Safety
1
2019
210
0.140
Why?
Hepatic Encephalopathy
1
2019
81
0.140
Why?
Humans
16
2025
125883
0.130
Why?
Drug Therapy
1
2017
84
0.130
Why?
Health Personnel
1
2021
527
0.130
Why?
Alcohol Drinking
1
2019
336
0.120
Why?
Self Report
1
2019
529
0.120
Why?
Patient Education as Topic
1
2019
448
0.120
Why?
Interdisciplinary Communication
1
2016
129
0.110
Why?
Systemic Inflammatory Response Syndrome
1
2016
189
0.110
Why?
Surgical Procedures, Operative
1
2017
219
0.110
Why?
Interprofessional Relations
1
2016
153
0.110
Why?
Hepatitis C
1
2017
379
0.100
Why?
Information Dissemination
1
2016
189
0.100
Why?
Metabolomics
1
2017
452
0.100
Why?
Gastrointestinal Diseases
1
2016
335
0.090
Why?
Clinical Trials, Phase III as Topic
2
2025
73
0.090
Why?
Disease Progression
1
2017
2104
0.090
Why?
Renal Replacement Therapy
2
2023
147
0.080
Why?
Treatment Outcome
6
2023
12354
0.080
Why?
Biomarkers
1
2019
3139
0.080
Why?
Physicians
1
2016
617
0.080
Why?
Double-Blind Method
2
2021
1589
0.060
Why?
Randomized Controlled Trials as Topic
2
2025
1178
0.060
Why?
Middle Aged
6
2025
27322
0.060
Why?
Canada
2
2016
299
0.060
Why?
Drug Therapy, Combination
2
2017
1145
0.050
Why?
Male
6
2025
62056
0.040
Why?
Infusions, Intravenous
1
2021
523
0.040
Why?
Female
6
2025
67886
0.040
Why?
Aged
3
2025
20022
0.040
Why?
Combined Modality Therapy
1
2021
1237
0.030
Why?
Placebos
1
2016
222
0.030
Why?
Survival Rate
1
2020
2054
0.030
Why?
Adult
3
2025
30246
0.030
Why?
Survival Analysis
1
2016
1473
0.020
Why?
Prognosis
1
2020
4691
0.020
Why?
Kidney
1
2016
1261
0.020
Why?
United States
1
2016
11149
0.010
Why?
Retrospective Studies
1
2016
16775
0.010
Why?
PAPPAS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_